MUROMACHI CHEMICALS INC. (JP:4885)

:4885

4885

MUROMACHI CHEMICALS INC.

RESEARCH TOOLSreports

Want to see JP:4885 full AI Analyst Report?

MUROMACHI CHEMICALS INC. (4885) Price & Analysis

0 Followers

4885 Stock Chart & Stats

¥827.00

-¥82.00(-7.25%)

At close: Jan 08 4:00 PM EST

¥827.00

-¥82.00(-7.25%)

Day’s Range― - ―

52-Week Range¥703.00 - ¥1,380.00

Previous CloseN/A

Volume1.18M

Average Volume (3M)8.80K

Market Cap

¥3.77B

Enterprise Value¥4.08B

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)12.5

Beta0.85

Next Earnings

Jul 10, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield4.25%

Share Statistics

EPS (TTM)23.26

Shares Outstanding4,095,500

10 Day Avg. Volume6,960

30 Day Avg. Volume8,803

Financial Highlights & Ratios

PEG Ratio-0.53

Price to Book (P/B)1.43

Price to Sales (P/S)0.53

P/FCF Ratio-30.96

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthSustained top-line expansion indicates the company is winning demand or market share across its product lines. Over multiple years this supports scalable fixed-cost absorption, funds reinvestment in R&D or capacity, and underpins durable earnings power even if margins ebb temporarily.

Operational MarginsStable gross margins and healthy EBIT/EBITDA imply efficient production and pricing discipline. These operational strengths provide lasting cash-generation potential and resilience to input cost volatility, supporting sustainable operating profitability over the medium term.

Improving Leverage ManagementAn improving debt-to-equity trend and stable equity ratio reflect deliberate balance-sheet repair, which increases financial flexibility. Progress on leverage reduces financing risk and helps preserve capacity to fund capex, dividends, or strategic initiatives over the coming months.

Bears Say

Weak Cash GenerationDeclining operating cash flow and negative free cash flow signal a structural gap between reported profits and actual cash conversion. Persistently weak cash generation can force reliance on external funding, constrain reinvestment, and pressure liquidity and dividend sustainability over several quarters.

Falling Net MarginA shrinking net margin points to rising non-operational costs or lower bottom-line efficiency, which erodes retained earnings and return metrics. If not addressed, it can weaken ability to build reserves, reduce ROE, and limit long-term capital allocation flexibility.

Remaining High LeverageAlthough leverage has improved, remaining elevated debt levels keep fixed obligations high and increase sensitivity to interest or demand shocks. This structural leverage can limit strategic optionality and elevate refinancing risk across the 2-6 month horizon if cash flow does not recover.

4885 FAQ

What was MUROMACHI CHEMICALS INC.’s price range in the past 12 months?

MUROMACHI CHEMICALS INC. lowest stock price was ¥703.00 and its highest was ¥1380.00 in the past 12 months.

What is MUROMACHI CHEMICALS INC.’s market cap?

MUROMACHI CHEMICALS INC.’s market cap is ¥3.77B.

When is MUROMACHI CHEMICALS INC.’s upcoming earnings report date?

MUROMACHI CHEMICALS INC.’s upcoming earnings report date is Jul 10, 2026 which is in 39 days.

How were MUROMACHI CHEMICALS INC.’s earnings last quarter?

MUROMACHI CHEMICALS INC. released its earnings results on Apr 14, 2026. The company reported ¥23.26 earnings per share for the quarter, beating the consensus estimate of N/A by ¥23.26.

Is MUROMACHI CHEMICALS INC. overvalued?

According to Wall Street analysts MUROMACHI CHEMICALS INC.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MUROMACHI CHEMICALS INC. pay dividends?

MUROMACHI CHEMICALS INC. pays a Semiannually dividend of ¥10 which represents an annual dividend yield of 4.25%. See more information on MUROMACHI CHEMICALS INC. dividends here

What is MUROMACHI CHEMICALS INC.’s EPS estimate?

MUROMACHI CHEMICALS INC.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MUROMACHI CHEMICALS INC. have?

MUROMACHI CHEMICALS INC. has 4,095,500 shares outstanding.

What happened to MUROMACHI CHEMICALS INC.’s price movement after its last earnings report?

MUROMACHI CHEMICALS INC. reported an EPS of ¥23.26 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.58%.

Which hedge fund is a major shareholder of MUROMACHI CHEMICALS INC.?

Currently, no hedge funds are holding shares in JP:4885

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

MUROMACHI CHEMICALS INC.

Muromachi Chemicals Inc. plans, produces, and distributes pharmaceuticals and health foods in Japan. It offers active pharmaceutical ingredients and intermediate synthesis products; commissioned processing services for pharmaceuticals; and commissioned synthesis services for radioactive and stable isotope tagged compounds used in pharmaceutical and agricultural metabolic testing, as well as imports and sells active pharmaceutical ingredients. The company also provides jelly and non-alcoholic beverage products. In addition, it offers ion-exchange resins, separation membranes, and ion-exchange fibers; and solutions that meet customers' needs with water-treatment products, including filter media, equipment, and chemicals, as well as commissioned chemical processing services. Further, the company provides functional adhesives; and product contamination removal and dust removal mats, and antistatic products for use in the electronics industry, as well as engages in the commissioned manufacturing and processing of functional pastes. The company was founded in 1917 and is headquartered in Omuta, Japan.